Haberkorn U - Search Results

1

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

Kratochwil C, Giesel FL, Eder M, Afshar-Oromieh A, Benešová M, Mier W, Kopka K, Haberkorn U. Kratochwil C, et al. Among authors: haberkorn u. Eur J Nucl Med Mol Imaging. 2015 May;42(6):987-8. doi: 10.1007/s00259-014-2978-1. Epub 2015 Jan 9. Eur J Nucl Med Mol Imaging. 2015. PMID: 25573634 No abstract available.

2

Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description.

Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P. Ziegler SI, et al. Among authors: haberkorn u. Eur J Nucl Med. 1996 Feb;23(2):169-77. doi: 10.1007/BF01731841. Eur J Nucl Med. 1996. PMID: 8925852

3

Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.

Eisenhut M, Hull WE, Mohammed A, Mier W, Lay D, Just W, Gorgas K, Lehmann WD, Haberkorn U. Eisenhut M, et al. Among authors: haberkorn u. J Med Chem. 2000 Oct 19;43(21):3913-22. doi: 10.1021/jm991079p. J Med Chem. 2000. PMID: 11052796

4

Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Among authors: haberkorn u. Bioconjug Chem. 2000 Nov-Dec;11(6):855-60. doi: 10.1021/bc000041k. Bioconjug Chem. 2000. PMID: 11087334

5

Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine.

Haberkorn U, Bellemann ME, Brix G, Kamencic H, Morr I, Traut U, Altmann A, Doll J, Blatter J, Kinscherf R. Haberkorn U, et al. Eur J Nucl Med. 2001 Apr;28(4):418-25. doi: 10.1007/s002590100489. Eur J Nucl Med. 2001. PMID: 11357491

6

Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone.

Haberkorn U, Kinscherf R, Krammer PH, Mier W, Eisenhut M. Haberkorn U, et al. Nucl Med Biol. 2001 Oct;28(7):793-8. doi: 10.1016/s0969-8051(01)00247-5. Nucl Med Biol. 2001. PMID: 11578900

7

A new precursor for the radiosynthesis of [18F]FLT.

Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, Haberkorn U, Eisenhut M. Martin SJ, et al. Among authors: haberkorn u. Nucl Med Biol. 2002 Feb;29(2):263-73. doi: 10.1016/s0969-8051(01)00289-x. Nucl Med Biol. 2002. PMID: 11823132

8

[18F]FLT; portrait of a proliferation marker.

Mier W, Haberkorn U, Eisenhut M. Mier W, et al. Among authors: haberkorn u. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):165-9. doi: 10.1007/s00259-001-0675-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926377 Review. No abstract available.

9

Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.

Henze M, Mohammed A, Mier W, Rudat V, Dietz A, Nollert J, Eisenhut M, Haberkorn U. Henze M, et al. Among authors: haberkorn u. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):324-30. doi: 10.1007/s00259-001-0703-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002706 Clinical Trial.

10

Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.

Henze M, Mohammed A, Schlemmer H, Herfarth KK, Mier W, Eisenhut M, Debus J, Haberkorn U. Henze M, et al. Among authors: haberkorn u. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1455-61. doi: 10.1007/s00259-002-0896-0. Epub 2002 Aug 20. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397464 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

577 results

Search Page